Market Cap
$2.34 B
+$116.21 M+5.22%
Fri, 07 Feb 2025 09:01:32 GMT
Summary
- As of February 7, 2025, LGND market capitalization is $2.34 billion, with a rise of +$116.21 million (+5.22%) during the most recent trading day.
- Over the past year, LGND market cap has increased by +$1.06 billion (+82.76%).
- LGND market cap is now -59.56% below its all-time high of $5.79 billion.
Performance
LGND Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Market Cap Formula
Market Cap = Price ✕ Shares Outstanding
LGND Market Cap Trends
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | Enterprise valueEnterprise value |
|---|---|---|---|---|
| todaytoday | +5.2% | +5.2% | +0.7% | +5.3% |
| 1 m1 month | +12.4% | +12.4% | - | +12.8% |
| 3 m3 months | -6.1% | -6.1% | - | - |
| 6 m6 months | +34.8% | +30.3% | - | - |
| ytdytd | +15.9% | +15.9% | - | +16.3% |
| 1 y1 year | +82.8% | +69.8% | +7.6% | +80.7% |
| 5 y5 years | +46.2% | +30.1% | +12.3% | +4.8% |
LGND Market Cap Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | $1.98 B | +18.3% | |
| 3 m | 3-month | $2.49 B | -6.1% | $1.89 B | +24.0% |
| 6 m | 6-month | $2.49 B | -6.1% | $1.74 B | +34.8% |
| 1 y | 1-year | $2.49 B | -6.1% | $1.19 B | +96.7% |
| 3 y | 3-year | $2.49 B | -6.1% | $864 M | +171.3% |
| 5 y | 5-year | $3.47 B | -32.5% | $864 M | +171.3% |
| alltime | all time | $5.79 B | -59.6% | $102 M | +2186.5% |
Ligand Pharmaceuticals Incorporated Market Cap History
| Date | Value |
|---|---|
| 2025 | $2.34 B(+15.9%) |
| 2024 | $2.02 B(+61.1%) |
| 2023 | $1.26 B(+10.9%) |
| 2022 | $1.13 B(-56.3%) |
| 2021 | $2.59 B(+61.9%) |
| 2020 | $1.60 B(-8.9%) |
| 2019 | $1.75 B(-37.7%) |
| 2018 | $2.82 B(-2.7%) |
| 2017 | $2.90 B(+36.3%) |
| 2016 | $2.12 B(-1.8%) |
| 2015 | $2.16 B(+107.6%) |
| 2014 | $1.04 B(-3.3%) |
| 2013 | $1.08 B(+144.0%) |
| 2012 | $441.32 M(+90.0%) |
| 2011 | $232.23 M(+33.4%) |
| Date | Value |
|---|---|
| 2010 | $174.02 M(-31.3%) |
| 2009 | $253.16 M(-2.7%) |
| 2008 | $260.14 M(-42.9%) |
| 2007 | $455.37 M(-58.2%) |
| 2006 | $1.09 B(+33.7%) |
| 2005 | $814.65 M(-4.1%) |
| 2004 | $849.38 M(-21.0%) |
| 2003 | $1.08 B(+180.2%) |
| 2002 | $383.68 M(-64.3%) |
| 2001 | $1.08 B(+35.4%) |
| 2000 | $794.50 M(+16.4%) |
| 1999 | $682.60 M(+28.5%) |
| 1998 | $531.13 M(+7.1%) |
| 1997 | $495.73 M(+4.8%) |
| 1996 | $473.01 M(+145.1%) |
| 1995 | $193.00 M |
FAQ
- What is Ligand Pharmaceuticals Incorporated market capitalization?
- What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
- What is LGND market capitalization year-to-date change?
- What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
What is Ligand Pharmaceuticals Incorporated market capitalization?
The current market cap of LGND is $2.34 B
What is the all time high market cap for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high market capitalization is $5.79 B
What is LGND market capitalization year-to-date change?
Ligand Pharmaceuticals Incorporated market capitalization has changed by +$320.84 M (+15.87%) since the beginning of the year
What is Ligand Pharmaceuticals Incorporated market cap year-on-year change?
Over the past year, LGND market capitalization has changed by +$1.06 B (+82.76%)